← Back to Patent Explorer
US4190575A Expired / Lapsed US ⏱️ 0.0 years remaining

Polypeptides related to somatostatin

Assignee: Wyeth LLC
•
Filing: 1977-12-27
•
Granted: 1980-02-26
•
Expires: 1997-12-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of the formula: ##STR1## wherein: X is H, Ala-Gly, Gly-Gly-Gly, Ala-D-Ala, acetyl, or benzoyl; X 1 is Arg or His; X 2 is Glu or Asp; X 3 is Trp or D-Trp; or 6-F-D-Trp; and X 4 is Cys- or D-Cys; or a non-toxic pharmaceutically acceptable acid addition salt thereof; inhibit the secretion of growth hormone and glucagon without materially affecting the secretion of insulin.

Inventors

  • 👤 Dimitrios Sarantakis

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 08:52
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/575; C07K14/655; C07K14/6555; C07K5/00; C07K5/04; C07K5/10; C07K5/1002; C07K5/1005; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S930/00; Y10S930/01; Y10S930/16

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 58 words
A compound of the formula: ##STR6## wherein: X is H, Ala-Gly, Gly-Gly-Gly, Ala-D-Ala, acetyl, or benzoyl; X 1 is Arg or His; X 2 is Glu or Asp; X 3 is Trp or D-Trp; or 6-F-D-Trp; and X 4 is Cys or D-Cys; or the reduced linear form thereof, or a non-toxic pharmaceutically acceptable acid addition salt thereof.
Claim 2
Dependent Claim 58 words
A compound of the formula: ##STR6## wherein: X is H, Ala-Gly, Gly-Gly-Gly, Ala-D-Ala, acetyl, or benzoyl; X 1 is Arg or His; X 2 is Glu or Asp; X 3 is Trp or D-Trp; or 6-F-D-Trp; and X 4 is Cys or D-Cys; or the reduced linear form thereof, or a non-toxic pharmaceutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim 13 words
A compound as defined in claim 1 which is L-cysteinyl-L-arginyl-L-glutamyl-L-phenylalanyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-cysteine cyclic (1-12) disulfide.
Claim 4
Dependent Claim 10 words
A compound as defined in claim 1 which is L-cysteinyl-L-arginyl-L-glutamyl-L-phenylalanyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-cysteine.
Claim 5
Dependent Claim 13 words
A compound as defined in claim 1 which is L-cysteinyl-L-histidyl-L-glutamyl-L-phenylalanyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-cysteine cyclic (1-12) disulfide.
Claim 6
Dependent Claim 10 words
A compound as defined in claim 1 which is L-cysteinyl-L-histidyl-L-glutamyl-L-phenylalanyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-cysteine.

References Cited (Backward Citations)

BE839405A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-02-25 1983-08-27 1984-02-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-02-25 1987-08-27 1988-02-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-02-25 1991-08-27 1992-02-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag